Wells Fargo
PPBT

Wells Fargo’s Purple Biotech PPBT Stock Holding History

Wells Fargo’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$60 – 7689
2023
Q3 		– Hold
0
– – – 6877
2023
Q2 		– Hold
0
– – – 6956
2023
Q1 		– Hold
0
– – – 6958
2020
Q3 		– Hold
0
– -$1K – 6751
2020
Q2 		– Hold
0
– – – 6186
2019
Q1 		– Sell
-5
Closed -$7K – 6359
2018
Q4 		$7K Hold
5
– – ﹤0.01% 6023
2018
Q3 		$17K Hold
5
– – ﹤0.01% 5867
2018
Q2 		$26K Hold
5
– – ﹤0.01% 5760
2018
Q1 		$22K Sell
5
-2
-29% -$10.1K ﹤0.01% 5790
2017
Q4 		$32K Buy
7
+3
+75% +$13.4K ﹤0.01% 5677
2017
Q3 		$18K Buy
+4
New +$14.9K ﹤0.01% 5742
2016
Q4 		– Sell
-1
Closed -$7K – 6403
2016
Q3 		$7K Hold
1
– – ﹤0.01% 5840
2016
Q2 		$4K Buy
+1
New +$10K ﹤0.01% 5853

Other funds holding PPBT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return
WAOI
Wealth Advisors of Iowa West Des Moines, Iowa $369M AUM 18.31% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Wells Fargo's PPBT Position: Q4 2023 in Review

Wells Fargo held its Purple Biotech (PPBT) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7689.

Wells Fargo first reported a position in PPBT in Q2 2016 and has held it in 8 quarters since. The position peaked at $32K in Q4 2017. 19 funds tracked by Wall St. Rank hold PPBT as of Q4 2023.

  • Wells Fargo held 0 shares of Purple Biotech worth $0 as of Q4 2023.
  • Wells Fargo left its Purple Biotech share count unchanged in Q4 2023.
  • Purple Biotech made up ﹤0.01% of Wells Fargo's portfolio in Q4 2023, its #7689 holding.
  • Wells Fargo first reported a position in Purple Biotech in Q2 2016 and has held it in 8 quarters since.
  • Wells Fargo's Purple Biotech position peaked at $32K in Q4 2017.
  • 19 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.